Wang Hung-Li, Chang Wen-Teng, Hsu Chia-Yu, Huang Pei-Chen, Chow Yu-Wen, Li Allen H
Department of Physiology, Chang Gung University School of Medicine, Tao-Yuan, Taiwan, ROC.
Biochem Pharmacol. 2002 Jul 15;64(2):257-66. doi: 10.1016/s0006-2952(02)01114-0.
Our recent study suggests that a cluster of Ser/Thr residues (T(354)S(355)S(356)T(357)) at the intracellular carboxyl tail of rat mu-opioid receptor (MOR1) is required for the development of short-term homologous desensitization. To investigate the functional role played by individual serine or threonine residue of this (TSST) cluster in the agonist-induced mu-opioid receptor desensitization, point mutant (T354A), (S355A), (S356A) and (T357A) mu-opioid receptors were prepared and stably expressed in human embryonic kidney 293 cells (HEK 293 cells). Similar to wild-type mu-opioid receptors, mutant (T354A) and (S356A) mu-opioid receptors stably expressed in HEK 293 cells developed homologous desensitization after 30 min pretreatment of DAMGO ([D-Ala(2),N-methyl-Phe(4),Gly-ol(5)]enkephalin), a specific mu-opioid receptor agonist. Substituting Ser(355)or Thr(357) with alanine resulted in a significant attenuation of agonist-induced mu-opioid receptor desensitization. In HEK 293 cells stably expressing double mutant (S355A/T357A) mu-opioid receptors, DAMGO pretreatment failed to significantly affect the efficacy and potency by which DAMGO inhibits forskolin-stimulated adenylyl cyclase activity. Consistent with the general belief that agonist-induced phosphorylation of guanine nucleotide binding protein (G protein)-coupled receptors is involved in homologous desensitization. Treating HEK 293 cells expressing wild-type mu-opioid receptors with 5 microM DAMGO for 30 min induced the receptor phosphorylation. Mutation of Ser(355) and Thr(357) also greatly impaired DAMGO-induced mu-opioid receptor phosphorylation. These results suggest that two C-terminal amino acids, Ser(355) and Thr(357), are required for short-term homologous desensitization and agonist-induced phosphorylation of mu-opioid receptors expressed in HEK 293 cells.
我们最近的研究表明,大鼠μ-阿片受体(MOR1)细胞内羧基末端的一组丝氨酸/苏氨酸残基(T(354)S(355)S(356)T(357))是短期同源脱敏发展所必需的。为了研究该(TSST)簇中单个丝氨酸或苏氨酸残基在激动剂诱导的μ-阿片受体脱敏中所起的功能作用,制备了点突变体(T354A)、(S355A)、(S356A)和(T357A)μ-阿片受体,并在人胚肾293细胞(HEK 293细胞)中稳定表达。与野生型μ-阿片受体相似,在HEK 293细胞中稳定表达的突变体(T354A)和(S356A)μ-阿片受体在特异性μ-阿片受体激动剂DAMGO([D-丙氨酸(2),N-甲基苯丙氨酸(4),甘氨醇(5)]脑啡肽)预处理30分钟后出现同源脱敏。用丙氨酸替代丝氨酸(355)或苏氨酸(357)会导致激动剂诱导的μ-阿片受体脱敏显著减弱。在稳定表达双突变体(S355A/T357A)μ-阿片受体的HEK 293细胞中,DAMGO预处理未能显著影响DAMGO抑制福斯高林刺激的腺苷酸环化酶活性的效力和效能。与普遍观点一致,即激动剂诱导的鸟嘌呤核苷酸结合蛋白(G蛋白)偶联受体的磷酸化参与同源脱敏。用5微摩尔/升DAMGO处理表达野生型μ-阿片受体的HEK 293细胞30分钟可诱导受体磷酸化。丝氨酸(355)和苏氨酸(357)的突变也极大地损害了DAMGO诱导的μ-阿片受体磷酸化。这些结果表明,两个C末端氨基酸,丝氨酸(355)和苏氨酸(357),是HEK 293细胞中表达的μ-阿片受体短期同源脱敏和激动剂诱导的磷酸化所必需的。